Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase NA 1Phase 4 1

Status

Completed 3Terminated 2Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 65INDUSTRY 9OTHER_GOV 3UNKNOWN 1

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Breast 9

Conditions

Neoplasms 10Breast Neoplasms 9Prostatic Neoplasms 7Multiple Myeloma 6Colorectal Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Neoplasms, Plasma Cell 3Lung Neoplasms 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Ovarian Epithelial 3Urinary Bladder Neoplasms 2Neoplasms by Site 2Mycoses 2Medication Adherence 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Leukemia 2Carcinoma, Transitional Cell 2COVID-19 2Adenocarcinoma 2Uveal Melanoma 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61pembrolizumab 60ribociclib 59Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Standard of Care × Clear all
NCT04567420 2026-06-03

DARE

Criterium, Inc.

Phase 2 Recruiting
70 enrolled
Breast

Breast Neoplasms

NCT07563595 2026-05-04

ELENI

iOMEDICO AG

Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Stemline Therapeutics, Inc.

Phase 3 Completed
478 enrolled 16 charts 1 FDA
Breast

Breast Neoplasms

NCT06309615 2025-05-29

PDxBRUTILITY

Precise Dx, Inc.

Not yet recruiting
300 enrolled
Breast

Breast Neoplasms

NCT06989450 2025-05-25

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Sidekick Health

Phase NA Recruiting
140 enrolled
Breast

Breast Neoplasms, Neoplasms, Medication Adherence

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Amgen

Phase 3 Completed
3,420 enrolled 19 charts
Breast

Breast Neoplasms

NCT03202446 2018-02-23

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Eske Corporation S.A.C

Phase 3 Terminated
18 enrolled
Breast

Breast Neoplasms

NCT00977379 2016-11-15

XERAD

Hoffmann-La Roche

Phase 2 Terminated
24 enrolled 20 charts
Breast

Breast Neoplasms

NCT01129336 2014-05-20

MACS1295

Novartis

Phase 4 Completed
44 enrolled 10 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡